Prelude Therapeutics Incorporated (PRLD) has 18 tenedores institucionales e internos conocidos registrados. El mayor tenedor es ORBIMED ADVISORS LLC con 10,119,756 acciones. Otros tenedores destacados incluyen Vaddi Krishna y Lim Bryant David.
En los últimos 12 meses, los internos han realizado 16 transacciones en PRLD acciones — 11 compras (valoradas en $4.06M) y 0 ventas (valoradas en RSU Award). Las compras internas han superado las ventas durante este período, lo que puede señalar confianza en las perspectivas de la empresa.
PRLD Participación de Insiders
Principal Titular
ORBIMED ADVISORS LLC
10,119,756 acciones
Compras (12 meses)
11
$4.06M valor
Ventas (12 meses)
0
$0.00 valor
Actividad de Transacciones (12 meses)
Principales Titulares Internos
| # |
Nombre |
Cargo |
Acciones en Propiedad |
Última Declaración |
Tamaño Relativo |
| 1 |
Orbimed Advisors Llc |
10 Percent Owner |
10,119,756 |
2023-05-24 |
|
| 2 |
Vaddi Krishna |
CEO |
837,000 |
2026-02-05 |
|
| 3 |
Lim Bryant David |
CLO, CFO, Corp Sec. |
275,000 |
2026-02-05 |
|
| 4 |
Combs Andrew |
Chief Chemistry Officer |
230,000 |
2026-02-05 |
|
| 5 |
Scherle Peggy |
Chief Scientific Officer |
230,000 |
2026-02-05 |
|
| 6 |
Chardonnet Laurent |
Chief Financial Officer |
150,000 |
2024-03-04 |
|
| 7 |
Sandor Victor |
Director |
121,285 |
2025-11-07 |
|
| 8 |
Piper Brian |
Chief Financial Officer |
115,650 |
2021-07-22 |
|
| 9 |
Mauro David J |
Chief Medical Officer |
95,000 |
2021-07-22 |
|
| 10 |
Morosini Deborah |
EVP, Chief of Clinical Affairs |
90,000 |
2022-02-17 |
|
| 11 |
Baker Bros. Advisors Lp |
10 Percent Owner |
76,000 |
2025-06-13 |
|
| 12 |
Friedman Paul A |
Director |
38,000 |
2025-06-13 |
|
| 13 |
Dier Mardi |
Director |
38,000 |
2025-06-13 |
|
| 14 |
Bonita David P |
10 Percent Owner |
38,000 |
2025-06-13 |
|
| 15 |
Babler Martin |
Director |
38,000 |
2025-06-13 |
|
| 16 |
Baker Brothers Life Sciences Lp |
Director |
34,300 |
2022-06-22 |
|
| 17 |
Huang Jane |
President, CMO |
18,750 |
2025-10-07 |
|
| 18 |
Pierce Christopher |
EVP and Chief of Business Oper |
3,750 |
2021-09-07 |
|
Transacciones Recientes (últimos 12 meses)
| Fecha |
Nombre |
Cargo |
Tipo |
Acciones |
Precio |
Valor |
| 2026-03-05 |
Brusky Sean P. |
Chief Business Officer |
Desconocido |
275,000 |
- |
- |
| 2026-02-04 |
Combs Andrew |
Chief Chemistry Officer |
Concesión de RSU |
230,000 |
$2.30 |
$529K |
| 2026-02-04 |
Vaddi Krishna |
CEO |
Concesión de RSU |
837,000 |
$2.30 |
$1.93M |
| 2026-02-04 |
Scherle Peggy |
Chief Scientific Officer |
Concesión de RSU |
230,000 |
$2.30 |
$529K |
| 2026-02-04 |
Lim Bryant David |
CLO, CFO, Corp Sec. |
Concesión de RSU |
275,000 |
$2.30 |
$632.5K |
| 2025-11-05 |
Sandor Victor |
Director |
Concesión de RSU |
121,285 |
$1.39 |
$168.59K |
| 2025-10-17 |
Dorton Katina |
Officer |
Desconocido |
- |
- |
- |
| 2025-10-04 |
Huang Jane |
President, CMO |
Ejercicio de Opciones (Venta) |
9,375 |
- |
- |
| 2025-07-04 |
Huang Jane |
President, CMO |
Ejercicio de Opciones (Venta) |
9,375 |
- |
- |
| 2025-06-12 |
Scherer Paul C |
Officer |
Desconocido |
- |
- |
- |
| 2025-06-12 |
Sandor Victor |
Director |
Concesión de RSU |
38,000 |
$1.04 |
$39.52K |
| 2025-06-12 |
Dier Mardi |
Director |
Concesión de RSU |
38,000 |
$1.04 |
$39.52K |
| 2025-06-12 |
Bonita David P |
10 Percent Owner |
Concesión de RSU |
38,000 |
$1.04 |
$39.52K |
| 2025-06-12 |
Babler Martin |
Director |
Concesión de RSU |
38,000 |
$1.04 |
$39.52K |
| 2025-06-12 |
Baker Bros. Advisors Lp |
10 Percent Owner |
Concesión de RSU |
76,000 |
$1.04 |
$79.04K |
| 2025-06-12 |
Friedman Paul A |
Director |
Concesión de RSU |
38,000 |
$1.04 |
$39.52K |
